Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Up 9.2% – Still a Buy?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares were up 9.2% on Friday. The stock traded as high as $0.84 and last traded at $0.84. Approximately 100 shares were traded during mid-day trading, a decline of 99% from the average session volume of 9,053 shares. The stock had previously closed at $0.7692.

Peak Pharmaceuticals Price Performance

The company’s fifty day simple moving average is $0.87 and its 200-day simple moving average is $1.16.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc. was a biotechnology company focused on developing natural product-based treatments for metabolic disorders. Its work centered on research and development rather than a broad portfolio of marketed medicines. Publicly available information about the company’s specific products, operating history, geographic reach and leadership is limited, so those details cannot be described reliably.

Further Reading

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.